Evidence map›Paper›PMID 41526391›Full record

ArticleScientific data2026

Single-cell and spatial transcriptomic profiling of cardiac fibroblasts following myocardial infarction.

Silvia C Hernández, Marina Ainciburu, Laura Sudupe, Nuria Planell, María López-Moreno, Amaia Vilas-Zornoza, Luis Diaz-Martinez, Jorge Cobos-Figueroa, Juan P Romero, Sarai Sarvide and 13 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Silvia C HernándezThe Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID http://orcid.org/0000-0002-6525-5296
Marina Ainciburu *Hemato-Oncology Program, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Laura Sudupe *Bioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
Nuria Planell *Computational Biology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.
María López-MorenoDepartment of Animal Biology, Universidad de Málaga, Málaga, Spain.
Amaia Vilas-ZornozaHemato-Oncology Program, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Luis Diaz-MartinezCentro de Supercomputación y Bioinnovación (SCBI), Universidad de Málaga, Málaga, Spain.
Jorge Cobos-FigueroaInstituto de Investigación Biomédica de Málaga (IBIMA-Plataforma BIONAND), Málaga, Spain.
Juan P RomeroHemato-Oncology Program, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Sarai SarvideHemato-Oncology Program, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Patxi San Martin-UrizHemato-Oncology Program, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.ORCID http://orcid.org/0000-0003-1483-4279
Ana López-PérezNavarrabiomed, Fundacion Miguel Servet, Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.ORCID http://orcid.org/0000-0002-5159-0122
Gloria AbizandaRegenerative Medicine Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.
Purificación Ripalda-CemboráinRegenerative Medicine Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.
Emma Muinos-LópezRegenerative Medicine Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.ORCID http://orcid.org/0000-0002-6618-4135
Vincenzo LaganiBioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
Jesper TegnerBioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.ORCID http://orcid.org/0000-0002-9568-5588
Ming WuDepartment of Cardiovascular Sciences, Clinical Cardiology, KU Leuven, Leuven, Belgium.
Stefan JanssensDepartment of Cardiovascular Sciences, Clinical Cardiology, KU Leuven, Leuven, Belgium.
José M Pérez-PomaresDepartment of Animal Biology, Universidad de Málaga, Málaga, Spain.
Felipe PrósperHemato-Oncology Program, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. fprosper@unav.es.ORCID http://orcid.org/0000-0001-6115-8790
Adrián Ruiz-VillalbaDepartment of Animal Biology, Universidad de Málaga, Málaga, Spain. adruiz@uma.es.
David Gómez-CabreroBioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia. david.gomezcabrero@kaust.edu.sa.ORCID http://orcid.org/0000-0003-4186-3788

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac fibroblasts (CFs) are key mediators of heart repair following myocardial infarction (MI). A specific CF subpopulation, termed Reparative Cardiac Fibroblasts (RCFs), has been shown to orchestrate scar formation and prevent ventricular rupture after MI. However, the timing of RCF appearance and the molecular events underlying this transition remain largely undefined. Here, we present a multi-modal dataset capturing the transcriptional dynamics of CFs during the early phase post-MI. Our integrative dataset combines bulk RNA sequencing, RNAscope in situ hybridization, and spatial transcriptomics to anatomically and temporally map the gene expression changes associated with the transition into RCFs. The dataset provides resources to characterize the distinct molecular programs that guide the emergence of RCFs from Periostin (Postn)

Indexed as

FibroblastsMyocardial InfarctionMyocardiumTranscriptomeAnimalsGene Expression ProfilingPeriostinSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisSpatial TranscriptomicsPeriostin

Identifiers

PMID41526391
PMCPMC12890913

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.